NCT06472765

Vaginal Ecosystem and Network in the United States Study

Enrolling by Invitation
Not specifiedAges 18–89Observational
Vaginal Biome Science
~3,250 participants
Updated 2025-07-01 on ClinicalTrials.gov
What's tested:Vaginal Swab Collection

At a glance

Recruiting sites
0 of 21 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Microbiome Analysis
Measured over Day 1
Bacterial Vaginosis
Candidiasis
Urinary Tract Infections
Genitourinary Syndrome of Menopause
Lichen Sclerosus
Lichen Planus
Vulvodynia
Endometriosis
Ureaplasma Infections
Cancer
Desquamative Inflammatory Vaginitis
21 sites across 14 states
California4
Maryland2
New York2
Oklahoma2
Oregon2
Hawaii1
Minnesota1
Nevada1
  • Kimberly Capone, PhD · PRINCIPAL_INVESTIGATOR · Vaginal Biome Science

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Healthy cis-gender women between ages 18 and 89

Exclusion

Pregnant or trying to conceive (i.e. IVF, IUI)
  • Microbiome AnalysisDay 1

    To analyze the vaginal microbiome in patients with diverse vaginal health conditions using next-generation sequencing (NGS) and a 56-panel PCR test to understand microbial diversity and implications for disease management.